Montreal, May 10, 2001
Andre De Villers, M.D., President and CEO of Theratechnologies Inc. present his report at the company annual meeting, May 10 in Montreal, CANADA.
Theratechnologies Inc is a Canadian biopharmaceutical company engaged in the fields of therapeuticc peptides and cell theraphy.
One of their products ; Theralux (tm) has reached Phase I/II status in CML ans is at a pivotal stage in NHL, bringing this product closer to commercialization
By the 2nd quater... more »
Montreal, May 10, 2001
Andre De Villers, M.D., President and CEO of Theratechnologies Inc. present his report at the company annual meeting, May 10 in Montreal, CANADA.
Theratechnologies Inc is a Canadian biopharmaceutical company engaged in the fields of therapeuticc peptides and cell theraphy.
One of their products ; Theralux (tm) has reached Phase I/II status in CML ans is at a pivotal stage in NHL, bringing this product closer to commercialization
By the 2nd quater of 2002, Theratechnologies expect to fullfill all the requirements to be listed on Nasdaq.
Photo by Pierre Roussel / Liaison
NOTE : Uncorrected Nikon D-1 JPEG opened as NTSC saved as Adobe RGB color space.. « less
Comments